Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSunrise Resources PLC Regulatory News (SRES)

Share Price Information for Sunrise Resources PLC (SRES)

Share Price is delayed by 15 minutes
Get Live Data
0.023    0.00 (0.00%)
Bid:
0.021
Ask:
0.025
Spread: 0.004 (19.048%)
Market Cap: £2.16m
SRES Live PriceLast checked at - London Stock Exchange

Intraday Sunrise Resources PLC Share Chart

£3m Equity Finance Facility Secured

25 Oct 2012 07:00

RNS Number : 4772P
Sunrise Resources Plc
25 October 2012
Β 

ο»Ώ

Β 

25 October 2012

SUNRISE RESOURCES PLC

Β 

Β£3m Equity Finance Facility Secured

Β 

Sunrise Resources plc ("Sunrise" or "the Company") is pleased to announce that it has entered into a Β£3 million Equity Financing Facility ("EFF") with Darwin Strategic Limited ("Darwin"). Darwin is a majority owned subsidiary of Henderson Global Investors' AlphaGen Volantis Fund.

Β 

Commenting on today's announcement, Patrick Cheetham, Executive Chairman, said: "This new Β£3 million facility provides Sunrise with an attractive, flexible source of funding which can be used entirely at the Company's discretion. The Directors will endeavour to use the facility to minimise dilution and maximise the value of Sunrise's projects for its shareholders.

Β 

"It is important that the Company diversifies the range of financial resources available. This facility strengthens Sunrise's ability to grow its business and the Board is delighted that institutional investors Darwin and Henderson Volantis have chosen to partner with us."

Β 

Anand Sambasivan, Chief Executive of Darwin, commented: "We are pleased to support Sunrise, its projects and its highly experienced management team."

Β 

Terms of the EFF

Β 

The EFF agreement with Darwin provides Sunrise with a Β£3 million facility which (subject to certain limited restrictions) can be drawn down at any time over the next three years. The timing and value of any draw down is at the sole discretion of the Company.

Β 

Sunrise is under no obligation to make a draw down and may make draw downs up to the total value of the EFF, by way of issuing subscription notices to Darwin. Following delivery of a subscription notice, Darwin will subscribe and the Company will allot to Darwin new ordinary shares in Sunrise ("Ordinary Shares").

Β 

The subscription price for any Ordinary Shares to be subscribed by Darwin under a subscription notice will be at a 5% discount to an agreed reference price determined during a nominated period of up to 15 trading days following delivery of a subscription notice (the "Pricing Period"). Sunrise is also obliged to specify in each subscription notice a minimum price (the "Floor Price") below which Ordinary Shares will not be issued to Darwin. The Company will have the right to modify that Floor Price at any time during the relevant Pricing Period. The number of Ordinary Shares issued on each draw down may not exceed 25% of the issued Ordinary Shares, as enlarged by the issue.

Β 

The number of Ordinary Shares which may be issued under any individual subscription notice will primarily be determined by reference to the average daily trading volume of Sunrise's ordinary shares over a nominated period of up to 15 trading days preceding the issue of the relevant subscription notice. The number of shares to be issued may be reduced in certain circumstances, including where the Floor Price is not maintained, the Company's shares not being traded or the Company having suffered a material adverse effect during the Pricing Period.

Β 

There is also an over-allotment facility available to Sunrise, under which Sunrise may authorise Darwin, at Darwin's discretion, to increase the amount of the draw down, subject to certain limited restrictions.

Β 

The issuance of a subscription notice is conditional upon the satisfaction of certain Subscription Notice Conditions which have been agreed between Darwin and the Company.

Β 

In conjunction with the EFF, Sunrise has entered into a warrant agreement with Darwin allowing Darwin to subscribe for up to 6,500,000 Ordinary Shares in the capital of the Company, such warrants to be exercisable at a price equal to a 40% premium to the volume weighted average price of the shares in the 5 trading day period following the day of announcement of the results of the technical and economic scoping study for the Company's Derryginagh project and at any time prior to the expiry of 36 months from 23 October 2012.

Β 

The Company is working towards completion of the Derryginagh scoping study by the end of October.

Β 

Β 

Further information:

Β 

Sunrise Resources plc Tel: +44 (0)845 868 4590

Patrick Cheetham, Executive Chairman

Β 

Northland Capital Partners Limited Tel: +44 (0)20 7796 8800

Gavin Burnell / Edward Hutton

Alice Lane /John-Henry Wicks (Broking)

Β 

Darwin Strategic Limited

Anand Sambasivan / Jamie Vickers Tel: +44 (0)20 7938 5700

Β 

Yellow Jersey PR Limited Tel: +44 (0)7768 537 739

Dominic Barretto

Β 

Β 

Notes to Editors

Β 

About Sunrise Resources plc

Β 

Sunrise Resources plc is a diversified mineral exploration and development specialist.

Β 

The Company's objective is to develop profitable mining operations to sustain the Company's wider exploration efforts and create value for shareholders through the discovery of world-class deposits.

Β 

The Company is evaluating a product opportunity for white barite in south-west Ireland and diamond exploration interests in Western Australia and Finland.

Shares in the Company trade on AIM under the symbol "SRES" http://www.sunriseresourcesplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCBKQDNABDDFKB
Date   Source Headline
4th Jun 20269:46 amRNSHALF-YEARLY REPORT 2026
6th May 20267:00 amRNSISSUE OF WARRANTS
30th Apr 20264:28 pmRNSTotal Voting Rights
23rd Apr 20263:08 pmRNSResult of WRAP Retail Offer
21st Apr 20264:00 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSWRAP Retail Offer for up to £50,000
20th Apr 20263:43 pmRNSHolding(s) in Company
17th Apr 20264:40 pmRNSHolding(s) in Company
17th Apr 20264:07 pmRNSHolding(s) in Company
17th Apr 202612:00 pmRNSHolding(s) in Company
13th Apr 202612:15 pmRNSPlacing and Issue of Equity
26th Mar 202611:16 amRNSVoting at AGM
25th Mar 202610:46 amRNSResult of AGM
23rd Mar 20261:50 pmRNSDIRECTORS’ DEALING
27th Feb 20267:00 amRNSANNUAL REPORT TO 30 SEPTEMBER 2025 & NOTICE OF AGM
20th Feb 202612:30 pmRNSAudited Results for the year to 30 September 2025
4th Feb 20265:56 pmRNSHolding(s) in Company
9th Jan 20269:48 amRNSUPDATE ON HAZEN PROJECT, NEVADA, USA
8th Jan 20267:00 amRNSPIOCHE SEPIOLITE PROJECT, NEVADA, USA
8th Dec 20257:00 amRNSHAZEN PROJECT, NEVADA, USA
3rd Nov 202510:50 amRNS-RGarfield Royalty Interest
31st Oct 20257:00 amRNSPioche Sepiolite Project - Update
28th Oct 20257:00 amRNSNominated Broker
1st Oct 20259:54 amRNSHolding(s) in Company
30th Sep 20252:43 pmRNSTotal Voting Rights
24th Sep 20253:00 pmRNSIssue of Shares following Conversion & TVR
16th Sep 202510:16 amRNSHolding(s) in Company
15th Sep 202510:31 amRNSCS NATURAL POZZOLAN PROJECT UPDATE
15th Sep 20259:28 amRNSHAZEN PROJECT UPDATE
7th Aug 202512:17 pmRNSHolding(s) in Company
1st Aug 20252:00 pmRNSResult of WRAP Retail Offer
31st Jul 20257:01 amRNSWRAP Retail Offer launches
31st Jul 20257:00 amRNSPlacing raised £200k, launch of WRAP retail offer
23rd Jul 20257:00 amRNSPioche Sepiolite Project - Update
21st Jul 20257:00 amRNSSale Option Agreement – Hazen Project
14th Jul 20253:25 pmRNSHolding(s) in Company
9th Jun 20257:00 amRNSConvertible Security – Extension of Term
3rd Jun 20252:03 pmRNS-RGarfield Royalty Interest
21st May 20257:00 amRNSHALF-YEARLY REPORT 2025
15th Apr 202512:00 pmRNSPioche Sepiolite Project – Positive Test Results
9th Apr 20257:00 amRNS-RGold & Silver Projects
2nd Apr 202512:00 pmRNS-RPioche Sepiolite Project
31st Mar 202510:32 amRNSDirectorate Change
31st Mar 20258:49 amRNSTotal Voting Rights
14th Mar 20254:44 pmRNSVoting at AGM
13th Mar 202511:50 amRNSResult of AGM
12th Mar 202512:07 pmRNSDIRECTORS’ DEALINGS, ISSUE OF EQUITY & TVR
10th Mar 202512:00 pmRNSAppointment of Non-Executive Director
28th Feb 20251:29 pmRNSTotal Voting Rights
17th Feb 20255:16 pmRNSIssue of Shares following Conversion & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.